BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 35260822)

  • 1. Ubiquitin ligase E3 HUWE1/MULE targets transferrin receptor for degradation and suppresses ferroptosis in acute liver injury.
    Wu Y; Jiao H; Yue Y; He K; Jin Y; Zhang J; Zhang J; Wei Y; Luo H; Hao Z; Zhao X; Xia Q; Zhong Q; Zhang J
    Cell Death Differ; 2022 Sep; 29(9):1705-1718. PubMed ID: 35260822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRL4B
    Liu F; Cao L; Zhang T; Chang F; Xu Y; Li Q; Deng J; Li L; Shao G
    Biochem Biophys Res Commun; 2018 Jun; 501(2):440-447. PubMed ID: 29738775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic PPARα function is controlled by polyubiquitination and proteasome-mediated degradation through the coordinated actions of PAQR3 and HUWE1.
    Zhao Z; Xu D; Wang Z; Wang L; Han R; Wang Z; Liao L; Chen Y
    Hepatology; 2018 Jul; 68(1):289-303. PubMed ID: 29331071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel SNP in HUWE1 promoter confers increased risk of NOA by affecting the RA/RARα pathway in Chinese individuals.
    Shan X; Zhang X; Huang G; Lv J; Ye Z; Jiang C; Jiang X; Cheng J; Lin H; Jiang H; Yue H; Wang Z; Xu W
    Andrology; 2024 Feb; 12(2):338-348. PubMed ID: 37290064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage-induced activation of CUL4B targets HUWE1 for proteasomal degradation.
    Yi J; Lu G; Li L; Wang X; Cao L; Lin M; Zhang S; Shao G
    Nucleic Acids Res; 2015 May; 43(9):4579-90. PubMed ID: 25883150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer.
    Gong X; Du D; Deng Y; Zhou Y; Sun L; Yuan S
    Invest New Drugs; 2020 Apr; 38(2):515-524. PubMed ID: 32008177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.
    Cheng YF; Tong M; Edge AS
    J Biol Chem; 2016 Sep; 291(40):21096-21109. PubMed ID: 27542412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1.
    Thompson JW; Nagel J; Hoving S; Gerrits B; Bauer A; Thomas JR; Kirschner MW; Schirle M; Luchansky SJ
    J Biol Chem; 2014 Oct; 289(42):28942-55. PubMed ID: 25147182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATG101 Degradation by HUWE1-Mediated Ubiquitination Impairs Autophagy and Reduces Survival in Cancer Cells.
    Lee J; Kim J; Shin J; Kang Y; Choi J; Cheong H
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between Huwe1 and autophagy in rat cerebral neuron oxygen‑glucose deprivation and reperfusion injury.
    He GQ; Chen Y; Liao HJ; Xu WM; Zhang W; He GL
    Mol Med Rep; 2020 Dec; 22(6):5083-5094. PubMed ID: 33173969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E3 ubiquitin ligase CHIP interacts with transferrin receptor 1 for degradation and promotes cell proliferation through inhibiting ferroptosis in hepatocellular carcinoma.
    Shao M; Qi K; Wang L; Yu X; Zhang Q; Yu L; Wang L; Yang C; Fan L
    Cell Signal; 2024 Jun; 118():111148. PubMed ID: 38521179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solenoid architecture of HUWE1 contributes to ligase activity and substrate recognition.
    Hunkeler M; Jin CY; Ma MW; Monda JK; Overwijn D; Bennett EJ; Fischer ES
    Mol Cell; 2021 Sep; 81(17):3468-3480.e7. PubMed ID: 34314700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.
    Wang X; Lu G; Li L; Yi J; Yan K; Wang Y; Zhu B; Kuang J; Lin M; Zhang S; Shao G
    Biochem Biophys Res Commun; 2014 Feb; 444(3):290-5. PubMed ID: 24342616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.
    Wang X; Lu G; Li L; Yi J; Yan K; Wang Y; Zhu B; Kuang J; Lin M; Zhang S; Shao G
    Biochem Biophys Res Commun; 2014 Feb; 444(4):549-54. PubMed ID: 24472556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E3 ubiquitin ligase HUWE1 acts through the N-Myc-DLL1-NOTCH1 signaling axis to suppress glioblastoma progression.
    Yuan Y; Wang LH; Zhao XX; Wang J; Zhang MS; Ma QH; Wei S; Yan ZX; Cheng Y; Chen XQ; Zou HB; Ge J; Wang Y; Zhang X; Cui YH; Luo T; Bian XW
    Cancer Commun (Lond); 2022 Sep; 42(9):868-886. PubMed ID: 35848447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobramycin suppresses HUWE1 degradation to control MCL-1 stability during tumour development.
    He J; Wu S; Li X; Tang L; Chen H; Qin L; Xie J; Lu T; Xu W
    Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1600-1610. PubMed ID: 32378766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HUWE1 promotes EGFR ubiquitination and degradation to protect against renal tubulointerstitial fibrosis.
    Zhu Q; Dong H; Bukhari AA; Zhao A; Li M; Sun Y; Zhang X; Cao C; Su D; Liang X
    FASEB J; 2020 Mar; 34(3):4591-4601. PubMed ID: 32017279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huwe1 interacts with Gadd45b under oxygen-glucose deprivation and reperfusion injury in primary Rat cortical neuronal cells.
    He GQ; Xu WM; Li JF; Li SS; Liu B; Tan XD; Li CQ
    Mol Brain; 2015 Dec; 8():88. PubMed ID: 26698301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitination by HUWE1 in tumorigenesis and beyond.
    Kao SH; Wu HT; Wu KJ
    J Biomed Sci; 2018 Sep; 25(1):67. PubMed ID: 30176860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HUWE1 and TRIP12 collaborate in degradation of ubiquitin-fusion proteins and misframed ubiquitin.
    Poulsen EG; Steinhauer C; Lees M; Lauridsen AM; Ellgaard L; Hartmann-Petersen R
    PLoS One; 2012; 7(11):e50548. PubMed ID: 23209776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.